Smolle, Maria A.
Hörlesberger, Nina
Musser, Ewald
Maier, Michael
Reinbacher, Patrick
Friesenbichler, Jörg
Leithner, Andreas
Maurer-Ertl, Werner
Funding for this research was provided by:
Johnson & Johnson (Vienna, Austria) Medtronic (Vienna, Austria) Alphamed-Fischer
Implantec
Article History
Received: 5 March 2019
Accepted: 9 October 2019
First Online: 31 October 2019
Competing interests
: WME has received financial support for presentations as well as research support by <i>Implantec (ImplanTec GmbH, Moedling, Austria)</i>. AL has received educational grants by <i>Johnson & Johnson (Vienna, Austria), Medtronic (Vienna, Austria)</i> and <i>Alphamed-Fischer (Lassnitzhoehe, Austria)</i>. AL is a board member of <i>EMSOS (European Musculo-Skeletal Oncology Society)</i>, <i>ÖGO (Austrian Society of Orthopaedic Surgeons)</i> and <i>ÖGOuT (Austrian Society of Orthopaedics and Trauma)</i>. MAS has no competing interest to declare. NH has no competing interest to declare. EM has no competing interest to declare. MM has no competing interest to declare. PR has no competing interest to declare. JF has no competing interest to declare.